Livforsakringsbolaget Skandia’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AGN
LP
BG
Livforsakringsbolaget Skandia's AGN Position: Q4 2018 in Review
Livforsakringsbolaget Skandia sold out of Allergan plc (AGN) in Q4 2018, closing a stake of 14,610 shares — an estimated $2.78M sold.
Livforsakringsbolaget Skandia first reported a position in AGN in Q2 2013 and held it in 22 quarters. The position peaked at $15.1M in Q4 2015. 1,007 funds tracked by Wall St. Rank hold AGN as of Q4 2018.
- Livforsakringsbolaget Skandia reported no remaining Allergan plc position as of Q4 2018 after selling out during the quarter.
- Livforsakringsbolaget Skandia sold 14,610 Allergan plc shares in Q4 2018, an estimated $2.78M.
- Livforsakringsbolaget Skandia first reported a position in Allergan plc in Q2 2013 and held it in 22 quarters.
- Livforsakringsbolaget Skandia's Allergan plc position peaked at $15.1M in Q4 2015.
- 1,007 funds tracked by Wall St. Rank held Allergan plc as of Q4 2018.
Based on Livforsakringsbolaget Skandia's 13F filing for Q4 2018, filed 6 Feb 2019.